Home › Funds › Linden Thomas Advisory Services, LLC › CPRX
Linden Thomas Advisory Services, LLC position in CPRX
Catalyst Pharmaceuticals Inc
Linden Thomas Advisory Services, LLC reported holding 176,004 shares of CPRX (Catalyst Pharmaceuticals Inc) in its Q2 2026 13F filing — a position valued at US$5.5M, representing 0.45% of its reported portfolio and ranking #42 among its reported holdings. Linden Thomas Advisory Services, LLC has disclosed CPRX holdings in 11 of the last 11 reported quarters, going back to Q4 2023.
How Linden Thomas Advisory Services, LLC's CPRX position evolved
Linden Thomas Advisory Services, LLC first disclosed a stake in CPRX in Q4 2023 at 11,077 shares (US$186K). The position peaked in Q2 2026 at 176,004 shares, worth US$5.5M. Across 11 filings, Linden Thomas Advisory Services, LLC increased the stake 9 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 176,004 shares valued at US$5.5M. Notable position changes include a 51% increase in Q1 2024, a 27% increase in Q2 2024, a 262% increase in Q2 2025.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2023 | 11.08K | $186.20K | New |
| Q1 2024 | 16.74K | $266.88K | Add |
| Q2 2024 | 21.33K | $330.34K | Add |
| Q3 2024 | 26.91K | $534.91K | Add |
| Q4 2024 | 32.64K | $681.18K | Add |
| Q1 2025 | 35.23K | $854.40K | Add |
| Q2 2025 | 127.43K | $2.77M | Add |
| Q3 2025 | 135.58K | $2.67M | Add |
| Q4 2025 | 139.90K | $3.27M | Add |
| Q1 2026 | 163.59K | $4.05M | Add |
| Q2 2026 | 176.00K | $5.53M | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CPRX and 13F data
CPRX (Catalyst Pharmaceuticals Inc) is a company whose sector is not yet classified in our data. 43 other funds we track also report a position in CPRX — the largest reported positions include BlackRock Inc (US$602.2M), Vanguard Group (US$196.8M), AMERICAN CENTURY COMPANIES INC (US$174.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CPRX
- BlackRock Inc 19.16M sh · $602.16M · Q2 2026
- Vanguard Group 8.43M sh · $196.81M · Q4 2025
- AMERICAN CENTURY COMPANIES INC 5.55M sh · $174.56M · Q2 2026
- STATE STREET CORP 6.86M sh · $169.93M · Q1 2026
- VANGUARD CAPITAL MANAGEMENT LLC 5.14M sh · $161.40M · Q2 2026
- DIMENSIONAL FUND ADVISORS LP 3.63M sh · $114.22M · Q2 2026
- GLAZER CAPITAL, LLC 3.60M sh · $113.24M · Q2 2026
- JPMorgan Chase & Co 3.17M sh · $99.89M · Q2 2026
- GEODE CAPITAL MANAGEMENT, LLC 3.15M sh · $99.03M · Q2 2026
- Geode Capital Management 3.15M sh · $99.03M · Q2 2026
- HBK INVESTMENTS L P 2.82M sh · $88.64M · Q2 2026
- Morgan Stanley 2.76M sh · $86.76M · Q2 2026